Nanotechnology-based ocular drug delivery systems: recent advances and future prospects

S Li, L Chen, Y Fu - Journal of Nanobiotechnology, 2023 - Springer
Ocular drug delivery has constantly challenged ophthalmologists and drug delivery
scientists due to various anatomical and physiological barriers. Static and dynamic ocular …

The role of trained immunity in COVID-19: Lessons for the next pandemic

MG Netea, A Ziogas, CS Benn… - Cell Host & Microbe, 2023 - cell.com
Trained immunity is a long-term increase in responsiveness of innate immune cells, induced
by certain infections and vaccines. During the last 3 years of the COVID-19 pandemic …

Bacterial-induced or passively administered interferon gamma conditions the lung for early control of SARS-CoV-2

KL Hilligan, S Namasivayam, CS Clancy… - Nature …, 2023 - nature.com
Abstract Type-1 and type-3 interferons (IFNs) are important for control of viral replication;
however, less is known about the role of Type-2 IFN (IFNγ) in anti-viral immunity. We …

Trained immunity-related vaccines: innate immune memory and heterologous protection against infections

A Ziogas, MG Netea - Trends in molecular medicine, 2022 - cell.com
The innate immune system is able to build memory-like features in response to certain
infections or vaccines, resulting in enhanced responsiveness upon (re) challenge with the …

Pharmacological inhibition of TBK1/IKKε blunts immunopathology in a murine model of SARS-CoV-2 infection

TR Ullah, MD Johansen, KR Balka, RL Ambrose… - Nature …, 2023 - nature.com
Abstract TANK-binding kinase 1 (TBK1) is a key signalling component in the production of
type-I interferons, which have essential antiviral activities, including against SARS-CoV-2 …

Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients

R Rouet, JY Henry, MD Johansen, M Sobti… - Nature …, 2023 - nature.com
Emerging variants of concern (VOCs) are threatening to limit the effectiveness of SARS-CoV-
2 monoclonal antibodies and vaccines currently used in clinical practice; broadly …

Intravenous administration of BCG protects mice against lethal SARS-CoV-2 challenge

KL Hilligan, S Namasivayam, CS Clancy… - Journal of Experimental …, 2022 - rupress.org
In addition to providing partial protection against pediatric tuberculosis, vaccination with
bacille Calmette-Guérin (BCG) has been reported to confer nonspecific resistance to …

Interpreting the results of trials of BCG vaccination for protection against COVID-19

CCA Noble, NL Messina, LF Pittet… - The Journal of Infectious …, 2023 - academic.oup.com
BCG vaccination has beneficial off-target (“nonspecific”) effects on nonmycobacterial
infections. On this premise, trials set out to investigate whether BCG provides off-target …

[HTML][HTML] Mucosal COVID-19 vaccines: Risks, benefits and control of the pandemic

D Miteva, M Peshevska-Sekulovska… - World Journal of …, 2022 - ncbi.nlm.nih.gov
Based on mucosal immunization to promote both mucosal and systemic immune responses,
next-generation coronavirus disease 2019 (COVID-19) vaccines would be administered …

Evidence for the heterologous benefits of prior BCG vaccination on COVISHIELD™ vaccine-induced immune responses in SARS-CoV-2 seronegative young Indian …

S Rakshit, V Adiga, A Ahmed, C Parthiban… - Frontiers in …, 2022 - frontiersin.org
This proof-of-concept study tested if prior BCG revaccination can qualitatively and
quantitively enhance antibody and T-cell responses induced by Oxford/AstraZeneca …